Bill
Bill > SB727
WI SB727
WI SB727Creating a medicinal psilocybin treatment fund and a pilot program to study the effects of medicinal psilocybin treatment on patients with post-traumatic stress syndrome at the University of Wisconsin-Madison and making an appropriation. (FE)
summary
Introduced
11/21/2023
11/21/2023
In Committee
11/21/2023
11/21/2023
Crossed Over
Passed
Dead
04/15/2024
04/15/2024
Introduced Session
2023-2024 Regular Session
Bill Summary
This bill creates a new separate nonlapsible trust fund designated as the medicinal psilocybin treatment fund and establishes a pilot program to study the effects of medicinal psilocybin treatment on patients with post-traumatic stress syndrome (PTSD). The medicinal psilocybin treatment pilot program created by this bill must be established by the Board of Regents of the University of Wisconsin System at the University of Wisconsin-Madison in collaboration with that institution's Transdisciplinary Center for Research in Psychoactive Substances and its School of Pharmacy. The individuals eligible to participate in the pilot program must be veterans who are 21 years of age or older and who suffer from treatment-resistant PTSD. Individuals who are law enforcement officers are not eligible to participate in the pilot program study. The psilocybin therapy provided by the pilot program must be provided through pathways approved by the federal Food and Drug Administration, and the research accomplished in the pilot program may be accomplished in conjunction with other medications approved by the federal Food LRB-5129/1 JAM:cjs&emw 2023 - 2024 Legislature SENATE BILL 727 and Drug Administration. The board must ensure that no health information disclosed in the course of conducting the program contains personally identifiable information. The researchers conducting the program must create reports for the governor and the appropriate standing committees of the legislature regarding progress of the pilot program and the studies conducted as part of the program. The medicinal psilocybin treatment fund created in this bill consists of donations, gifts, grants, bequests, moneys transferred from the general fund, and all earnings and other investment income of the fund. This trust fund is managed by the State of Wisconsin Investment Board. Moneys in the fund may be expended for the purpose for which any donation, gift, grant, or bequest is made and for the administration of the pilot program. For further information see the state fiscal estimate, which will be printed as an appendix to this bill.
AI Summary
This bill creates a new separate nonlapsible trust fund designated as the medicinal psilocybin treatment fund and establishes a pilot program to study the effects of medicinal psilocybin treatment on patients with post-traumatic stress syndrome (PTSD) at the University of Wisconsin-Madison. The pilot program is open to veterans aged 21 or older who suffer from treatment-resistant PTSD, but excludes law enforcement officers. The psilocybin therapy provided in the program must be approved by the federal Food and Drug Administration, and the research may be conducted in conjunction with other FDA-approved medications. The Board of Regents of the University of Wisconsin System must ensure that no personally identifiable health information is disclosed, and must submit regular progress reports and final results to the governor and legislature. The medicinal psilocybin treatment fund consists of donations, gifts, grants, bequests, and transfers from the general fund, and is managed by the State of Wisconsin Investment Board.
Committee Categories
Education
Sponsors (23)
Melissa Agard (D)*,
Dianne Hesselbein (D)*,
Jesse James (R)*,
Chris Larson (D)*,
Kelda Roys (D)*,
Mark Spreitzer (D)*,
Clint Anderson (D),
Jimmy Anderson (D),
Mike Bare (D),
Robert Brooks (R),
Dave Considine (D),
James Edming (R),
Jodene Emerson (D),
Nate Gustafson (R),
Jenna Jacobson (D),
Alex Joers (D),
Dave Murphy (R),
Tod Ohnstad (D),
Sylvia Ortiz-Velez (D),
Melissa Ratcliff (D),
Angie Sapik (R),
Katrina Shankland (D),
Christine Sinicki (D),
Last Action
Failed to pass pursuant to Senate Joint Resolution 1 (on 04/15/2024)
Bill Topics
Education
- ‐ Higher Education
Health
- ‐ Mental Illness, Mental Retardation, and Deinstitutionalization
- ‐ Research and Development
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location | Created |
|---|---|---|
| State Bill Page | https://docs.legis.wisconsin.gov/2023/proposals/reg/sen/bill/sb727 | 11/21/2023 |
| SB727 ROCP for Committee on Universities and Revenue | https://docs.legis.wisconsin.gov/2023/related/records/senate/universities_and_revenue/1805090.pdf | 08/30/2024 |
| Fiscal Note - SB727: Fiscal Estimate From UWS | https://docs.legis.wisconsin.gov/2023/related/fe/sb727/sb727_uws.pdf | 01/04/2024 |
| BillText | https://docs.legis.wisconsin.gov/document/proposaltext/2023/REG/SB727.pdf | 11/21/2023 |
Loading...